Phlebotomy Guidelines in Congenital Cyanotic Cardiac Patients
Perform therapeutic phlebotomy ONLY when hemoglobin exceeds 20 g/dL AND hematocrit exceeds 65% WITH symptomatic hyperviscosity (headache, fatigue, poor concentration), and ONLY after confirming the patient is not dehydrated or iron deficient. 1, 2
Indications for Phlebotomy (Class I Recommendation)
The ACC/AHA and ESC guidelines are in complete agreement on this critical point:
- Hemoglobin > 20 g/dL
- Hematocrit > 65%
- Presence of moderate to severe hyperviscosity symptoms (headache, increasing fatigue, poor concentration)
- Absence of dehydration (must be ruled out first)
- Absence of iron deficiency (must be ruled out first) 1, 3, 2
How to Perform Phlebotomy
When indicated, use isovolumic replacement:
- Remove 400-500 mL of blood (approximately 1 unit)
- Simultaneously replace with 750-1000 mL of isotonic saline or dextrose solution
- This maintains circulating volume while reducing viscosity 3, 2
What NOT to Do (Class III Recommendation)
Repeated routine phlebotomies are contraindicated because they cause:
- Iron depletion
- Microcytic red blood cells (which paradoxically increase viscosity more than normocytic cells)
- Decreased oxygen-carrying capacity
- Increased stroke risk 1, 2
The ESC guidelines explicitly warn that microcytosis from inappropriate phlebotomies was the strongest independent predictor for cerebrovascular events 3. This is a critical safety concern that makes routine phlebotomy dangerous.
Pre-Phlebotomy Assessment Algorithm
Before considering phlebotomy, systematically evaluate:
- Hydration status: Rehydrate with oral or IV normal saline as first-line therapy 4
- Iron status: Check MCV (mean corpuscular volume) and ferritin
- Symptom assessment: Determine if symptoms truly reflect hyperviscosity versus other causes
- Baseline hematocrit: Compare current level to patient's usual baseline 4
Iron Deficiency Management
If iron deficiency is present (MCV < 80 fL):
- Iron supplementation is indicated 3
- Monitor closely for rebound erythrocytosis (rapid increase in red cell mass)
- Oral iron is preferred but may cause dramatic hematocrit increases requiring monitoring 2
- IV iron supplementation in pulses if oral iron is not tolerated 2
- Continue until ferritin and transferrin saturation normalize, then discontinue 2
Critical Pitfalls to Avoid
Most important: The compensatory erythrocytosis in cyanotic heart disease is a physiologic adaptation to improve oxygen transport. Most patients have stable, compensated erythrocytosis requiring no intervention 2. The primary cause of complications is aggressive phlebotomy or blood loss, not the elevated hematocrit itself 2.
Common errors:
- Phlebotomizing based solely on hematocrit level without symptoms
- Failing to assess hydration status first
- Not screening for iron deficiency before phlebotomy
- Attempting to maintain arbitrary "target" hematocrit levels
- Performing routine scheduled phlebotomies 5
Additional Context
The 2010 ESC guidelines emphasize that severity of secondary erythrocytosis per se is not a risk factor for cerebrovascular accidents 3. There is no exponential relationship justifying a specific "safe" hematocrit cutpoint, and hyperviscosity symptoms do not correlate well with measured hematocrit 4. This reinforces that treatment decisions must be symptom-driven, not number-driven.
The 2019 AHA/ACC guidelines note that after adequate hydration, phlebotomy with equal volume fluid replacement is sometimes performed when hematocrit remains higher than baseline with persistent symptoms, or when there is evidence of end-organ damage attributable to hyperviscosity (myocardial ischemia, transient ischemic attack/stroke) 4.
Preoperative phlebotomy: There is no clear role for routine preoperative phlebotomy to improve coagulation properties 4. Use only if meeting the standard symptomatic criteria above.